{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-061326","form_type":"8-K","ticker":"RVP","cik":"0000946563","company_name":"RETRACTABLE TECHNOLOGIES INC","filed_at":"2023-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.961714+00:00","generated_at":"2026-06-15T00:25:30.513968+00:00","sec_items":["8.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Retractable Q1 2023 sales down 75% to $11.0M; operating loss of $2.7M vs $9.7M profit a year ago","bullets":["Total net sales $11.0M for Q1 2023, vs $44.7M in Q1 2022; no U.S. government syringe orders.","Operating loss of $2.7M compared to operating income of $9.7M in prior-year period.","Domestic unit sales fell 77.4%; international revenue down 70.3% due to fewer vaccination campaign orders.","Sales & marketing expenses increased ~33% mainly in travel, trade shows, and sales headcount.","Invested ~$9.0M in U.S. government-backed mutual funds; restructured equity securities by ~$6.0M."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-061326","json":"https://secwatch.observer/filing/0001104659-23-061326.json","markdown":"https://secwatch.observer/filing/0001104659-23-061326.md","text":"https://secwatch.observer/filing/0001104659-23-061326.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946563/000110465923061326/0001104659-23-061326-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946563/000110465923061326/tm2315891d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T00:25:30.513968+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}